Fort Collins, Colorado, Sept. 15, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, "Small Scale Bioreactor Market Size, Trends, Growth, Share, Statistics Analysis Report, By Capacity (5 ML-100 ML, 100 ML-250 ML, 250 ML-500 ML, 500 ML-1), By Product (Single-use Bioreactors And Reusable Bioreactors), By End-user, By Region, And Segment Forecasts, 2023-2032.”
According to DataHorizzon Research, The small-scale bioreactors market size was valued at USD 1.8 Billion in 2022 and is expected to reach USD 7.5 Billion by 2032 at a CAGR of 15.2%. Small scale bioreactors are essential in laboratory and pilot studies for developing and optimizing biological experiments. These vessels are utilized to cultivate microorganisms, cells, and tissues while simultaneously studying biological processes under controlled conditions. Bioreactors are an indispensable tool for scientific research and experimentation, specifically designed to replicate the ideal environment for the growth and metabolism of biological cultures.
Bioreactors are vessels or devices that conduct biological reactions and cultivate various organisms in favorable environments, such as yeast, bacteria, or animal cells. These reactors provide a sustainable environment for the growth of cells and the formation of products. The growing need for biopharmaceuticals, cell-based therapies, and personalized medicine is driving the expansion of the small-scale bioreactors market. These small scale systems aid in the efficient development and optimization of processes, ultimately leading to reduced costs and a shorter time-to-market. The growth of the biopharmaceutical and cell therapy industries drives the demand for small scale bioreactors. These systems are cost-effective and offer accurate simulation of large-scale bioprocessing, which reduces cost and time for research and development.
Request Sample Report: https://datahorizzonresearch.com/request-sample-pdf/small-scale-bioreactor-market-2352
Report Snapshot:
| Report Title | Small Scale Bioreactor Market |
| Market Size in 2022 | USD 1.8 Billion |
| Market Size by 2032 | USD 7.5 Billion |
| CAGR from 2023 to 2032 | 15.2% |
| Largest Market | North America |
| Forecast Period | 2023 to 2032 |
| Historic Period | 2021 |
| Base Year | 2022 |
| Report Scope & Coverage | Market Size, estimations, competitor analysis, trends and growth factors |
| By Capacity | 5 ML-100 ML, 100 ML-250 ML, 250 ML-500 ML, 500 ML-1 L, 1L-3L, and 3L-5L |
| By Product | Single-use bioreactors and reusable bioreactors |
| By End-user | Biopharmaceutical industries, contract research organization, and contract manufacturing organizations |
| Region | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. |
| Countries Covered | U.S., Canada, U.K., Germany, France, China, Japan, India, South Korea, Brazil, Mexico, UAE, The Middle East, Saudi Arabia, South Africa |
| Major Market Players | Thermo Fisher, Eppendorf AG, Merck KGaA, Danaher Corporation, Getinge AB, Ori biotech, Solaris Biotechnology, Miltenyi Biotec, Infors AG, Lonza Group. |
Segmentation Overview:
The small scale bioreactors market has been segmented as capacity, product, end-user, and region. The market is currently dominated by 1L-3L capacity bioreactors, widely available in laboratories. As a result, most industry players significantly offer these products. Regarding product type, reusable bioreactors are the most popular due to their affordability, ease of use, and longer lifespan. Although they require thorough cleaning procedures, they are still highly usable and preferred for long-term use. These bioreactors can be installed in a fixed location and offer many benefits over other types.
North America had the highest market share in 2022. This was due to increased investments in biopharmaceutical research, driven by the growing incidences of chronic diseases and the demand for new biological drugs. Additionally, the use of advanced equipment, such as small scale bioreactors contributes to this trend.
Buy This Research Report: https://datahorizzonresearch.com/checkout-page/small-scale-bioreactor-market-2352
Key Developments in the Small scale Bioreactors Market:
- Ori Biotech, known for its expertise in cell and gene therapy manufacturing technologies, announced a partnership with the Cell Therapy Manufacturing Center in 2023. This collaborative venture between National Resilience Inc. and MD Anderson Cancer Center aims to create industrial manufacturing processes for cell therapies.
- Solaris, a Donaldson brand renowned for its innovation and commitment to sustainability, is excited to participate in the upcoming Future Food-Tech Alternative Proteins event in New York in 2023. As a leading provider of advanced filtration solutions for benchtop, pilot, and industrial bioreactors, Solaris is dedicated to transforming the alternative protein industry and promoting positive change in food production.
Small Scale Bioreactors Market Report Highlights:
- The small scale bioreactors market is expected to reach USD 7.5 Billion at a CAGR of 15.2% by 2032. Small scale bioreactors cultivate microorganisms, cells, and tissues for scientific research under controlled conditions. The market for small scale bioreactors is expanding due to the increasing demand for biopharmaceuticals, cell-based therapies, and personalized medicine, resulting in cost-effective and timely production.
- The market is dominated by 1L-3L bioreactors, which allows parallel processing of multiple experiments. Reusable bioreactors are popular for their affordability, offer many benefits, and have a long lifespan despite the need for regular maintenance.
- North America market dominance is fueled by the presence of biopharmaceutical and biotechnology companies, the rising incidence of chronic diseases, and the growing use of products and innovations.
- The key players in Small Scale bioreactors market report include Thermo Fisher, Eppendorf AG, Merck KGaA, Danaher Corporation, Getinge AB, Ori biotech, Solaris Biotechnology, Miltenyi Biotec, Infors AG, and Lonza Group.
Looking Exclusively For Region/Country Specific Report? https://datahorizzonresearch.com/ask-for-customization/small-scale-bioreactor-market-2352
OR
Ask For Discount https://datahorizzonresearch.com/ask-for-discount/small-scale-bioreactor-market-2352
Small Scale Bioreactor Market Report Segmentation:
Small Scale Bioreactor Market, By Capacity (2023-2032)
- 5ML-100ML
- 100ML-250ML
- 250ML-500ML
- 500ML-1L
- 1L-3L
- 3L-5L
Small Scale Bioreactor Market, By Product (2023-2032)
- Single-use Bioreactors
- Reusable Bioreactors
Small Scale Bioreactor Market, By End-user (2023-2032)
- Biopharmaceutical industries
- Contract research organization
- Contract Manufacturing Organizations
Small Scale Bioreactor Market, By Region (2023-2032)
- North America
-
- U.S.
- Canada
- Europe
-
- U.K.
- Germany
- France
- Rest of Europe
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
-
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
About DataHorizzon Research:
DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.
Contact:
Mail: sales@datahorizzonresearch.com
Ph: +1-970-672-0390
Website: https://datahorizzonresearch.com/
Follow Us: LinkedIn
Recent Publications
Remote Patient Monitoring Market 2023 to 2032
Sleep Apnea Devices Market 2023 to 2032
Telehealth Market 2023 to 2032
DNA Synthesizer Market 2023 to 2032
Cell Therapy Market 2023 to 2032
